Key facts
- It has raised $54.3M; the latest was PE Growth/Expansion ($27.5M) in Jan 2025.
- Notable investors include BDC Capital, iGan Partners, EDC Investments, Hayfin Capital Management, NewHealth Ventures — 6 tracked in total.
- Status: Acquired/Merged (Operating Subsidiary).
- ·The complete investor list — 6 names
- ·Watchlist + deal alerts for MolecuLight
- ·The full record, as it builds
Funding rounds
No funding rounds for MolecuLight are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About MolecuLight
Developer of portable handheld optical imaging devices designed to visualize bacteria and measure wounds at the point of care. The company's portable handheld optical imaging devices are used for the analysis and visual detection of bacteria, procedural guidance, and assessment of viable and nonviable tissue, enabling medical practitioners to choose the right therapy, at the right time for their patients.
- Sector
- Healthcare
- HQ
- Toronto, Canada
- Founded
- 2012
- Employees
- 47
- Website
- moleculight.com/
- Ownership
- Acquired/Merged (Operating Subsidiary)
MolecuLight doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in MolecuLight shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on MolecuLight in its N-PORT filings yet. We sweep new filings monthly.